Fuzeon and Jaundice cholestatic - a phase IV clinical study of FDA data

Summary:

Jaundice cholestatic is reported as a side effect among people who take Fuzeon (enfuvirtide), especially for people who are female, 50-59 old, have been taking the drug for 6 - 12 months also take Imodium, and have Depression.

The phase IV clinical study analyzes which people have Jaundice cholestatic when taking Fuzeon. It is created by eHealthMe based on reports of 3,001 people who have side effects when taking Fuzeon from the FDA, and is updated regularly.

What is Fuzeon?

Fuzeon has active ingredients of enfuvirtide. eHealthMe is studying from 3,007 Fuzeon users. Check the latest studies of Fuzeon.

What is Jaundice cholestatic?

Jaundice cholestatic is found to be associated with 532 drugs and 984 conditions by eHealthMe. Check the latest studies of Jaundice cholestatic.

On Aug, 09, 2026

3,001 people reported to have side effects when taking Fuzeon.
Among them, 12 people (0.4%) have Jaundice cholestatic.

Could Fuzeon cause Jaundice cholestatic?

Among these 12 people:

How long have people been on Fuzeon when they have Jaundice cholestatic? *

What is the gender of people who have Jaundice cholestatic when taking Fuzeon? *

female: 91.67 %
male: 8.33 %

What is the age of people who have Jaundice cholestatic when taking Fuzeon? *

What are other drugs people take besides Fuzeon? *

What are other side effects people have besides Jaundice cholestatic? *

Hypomania (a mild form of mania, marked by elation and hyperactivity): 11 people, 91.67%
Blood Bilirubin Increased: 11 people, 91.67%
Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 11 people, 91.67%
Psychotic Disorder: 11 people, 91.67%
Pneumonia: 11 people, 91.67%
Gallstones (stone formation by bile component): 11 people, 91.67%
Hepatic Enzyme Increased: 11 people, 91.67%
Nausea And Vomiting: 11 people, 91.67%
Nausea (feeling of having an urge to vomit): 11 people, 91.67%
Hepatotoxicity (chemical-driven liver damage): 11 people, 91.67%

What are the existing conditions these people have? *

Psychotic Disorder: 9 people, 75.00%
Musculoskeletal Stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves): 9 people, 75.00%
Hypomania (a mild form of mania, marked by elation and hyperactivity): 9 people, 75.00%
Hiv Infection: 9 people, 75.00%
Depression: 9 people, 75.00%
Pain In Extremity: 7 people, 58.33%
Seasonal Allergy (allergic condition due to certain season): 1 person, 8.33%
Hepatitis C: 1 person, 8.33%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 8.33%
Allergic Rhinitis: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Fuzeon and have Jaundice cholestatic?

- Check whether Jaundice cholestatic is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Fuzeon:

Fuzeon (3,007 reports)

Browse all side effects of Fuzeon:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Jaundice cholestatic:

Jaundice cholestatic (532 drugs)

Browse all the conditions that are associated with Jaundice cholestatic:

Jaundice cholestatic (984 conditions)

Related publications that referenced our studies

Agrawal A, Rao M, Jasdanwala S, Mathur A, Eng M, "Cephalexin Induced Cholestatic Jaundice", Case reports in gastrointestinal medicine, 2014 Aug .
Agrawal A, Rao M, Jasdanwala S, Mathur A, Eng M, "Cephalexin Induced Cholestatic Jaundice", Case reports in gastrointestinal medicine, 2014 Aug .

How the study uses the data?

The study uses data from the FDA. It is based on enfuvirtide (the active ingredients of Fuzeon) and Fuzeon (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.